Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPain ManagementCentene lysis of epidural lesions Coverage | OpenP…
    Ask Trek AI about this page
    CurrentCentenePolicy CP MP.116

    Lysis of Epidural Lesions

    Customize your policy alerts

    Sign up for Centene Policy CP MP.116 alerts

    Get alerted when Policy CP MP.116 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines Centene's coverage stance and criteria for percutaneous and endoscopic lysis of epidural adhesions (epidural adhesiolysis) for members with chronic low back and lower extremity pain. Applies to providers submitting claims to Centene-affiliated health plans.

    Policy Summary
    PayerCentene
    PolicyLysis of Epidural Lesions
    Policy CodePolicy CP MP.116
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionObtain prior authorization when requesting services billed with CPT 62263 or 62264 per plan rules.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Not supportedPolicy stance
    6 RCTs

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Hayes review
    62263, 62264CPT codes cited
    NICE 2010NICE guidance

    Coverage Determination and Criteria

    General coverage determination

    Covered when ALL of the following are met:

    Policy stance: Centene policy states that current medical literature does not support the efficacy of lysis of epidural lesions, including percutaneous epidural adhesiolysis and endoscopic epidural adhesiolysis, with or without use of an indwelling epidural Racz catheter.

    This is the explicit coverage conclusion of the policy.

    It is the policy of Centene-affiliated health plans that lysis of epidural lesions — including percutaneous epidural adhesiolysis and endoscopic epidural adhesiolysis, with or without use of an indwelling epidural Racz catheter — is not supported by current medical literature and therefore is excluded from coverage.

    Although a Hayes review identified six randomized controlled trials and reported limited, low-quality evidence suggesting potential short- and intermediate-term benefit of percutaneous adhesiolysis in select patients who have failed conservative therapy, the evidence base is small, of limited quality, and characterized by uncertain long-term outcomes. For these reasons, and because the overall literature does not reliably demonstrate efficacy, the procedure is considered not supported by current evidence and is not covered under this policy.

    Coding References

    Referenced CPT CodesCPT
    62263Percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 2 or more days.
    62264Percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 1 day.

    Provider Responsibilities and Billing Guidance

    Prior Authorization

    Prior authorization required for CPT 62263 / 62264

    Obtain prior authorization per plan rules when requesting services billed with CPT 62263 or 62264, because the policy states coverage is restricted by the policy stance that current medical literature does not support efficacy for lysis of epidural lesions.

    • Codes to reference: 62263, 62264
    • Follow plan-specific prior authorization submission process
    Step Therapy

    Conservative therapy failure is noted in the evidence but policy finds insufficient efficacy

    Although studies and guideline summaries commonly evaluate adhesiolysis after failure of conservative therapy, the policy concludes that current literature does not support the efficacy of lysis of epidural lesions.

    • Supporting evidence (Hayes review and guideline updates) often describes patient populations with prior conservative treatment failures.

    Clinical Background

    Epidural adhesiolysis is performed to mechanically or chemically disrupt epidural scar and adhesions that may contribute to chronic low back and radicular pain, commonly in patients with prior spinal surgery (failed back surgery/post‑laminectomy syndromes) or degenerative spinal disease. Techniques include percutaneous catheter-based disruption and injection (often using agents such as hypertonic saline, steroids, analgesics, or hyaluronidase) with fluoroscopic localization, as well as endoscopic epidural adhesiolysis (epiduroscopy), which uses spinal endoscopy to directly visualize and mechanically divide adhesions and deliver targeted injectate to affected nerve roots.

    Definitions of Techniques

    Percutaneous epidural adhesiolysis — technique and agents
    DefinitionInjection-based or mechanical catheter disruption of epidural adhesions, often using hypertonic saline, steroids, analgesics, or hyaluronidase with fluoroscopic localization
    Common agents usedHypertonic saline, steroids, analgesics, and hyaluronidase may be included in the injectate to mechanically disrupt adhesions and improve penetration into scar tissue
    Mechanical techniqueCatheter manipulation or mechanical disruption during the procedure can physically break adhesions; catheter may be left in place for serial treatment sessions in some protocols
    LocalizationProcedures use radiologic localization (fluoroscopy) to identify non-filling lesions and guide injectate placement
    Indications contextTypically performed for chronic low back and radicular pain associated with epidural fibrosis, often after prior spinal surgery or degenerative spine disease

    Role of Prior Conservative Therapy in Evidence and Policy

    Conservative treatment requirements (context)

    Context from evidence and guidelines (informational; does not change the policy coverage conclusion):

    Context: Supporting literature and guidelines commonly evaluate adhesiolysis in patients who have failed conservative therapy; however, the policy concludes that available evidence does not demonstrate sufficient efficacy to support coverage.

    Hayes review identified a small body of low-quality RCT evidence suggesting potential short- and intermediate-term benefit in patients who failed conservative therapy, but long-term outcomes are uncertain and evidence is limited. ASIPP guideline updates note limited high-quality RCTs and consider adhesiolysis in patients after failure of conservative treatment.

    Procedure Frequency and Session Descriptions

    CPT code descriptions — single‑day vs multi‑day sessions
    62263Percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 2 or more days.
    62264Percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 1 day.
    Coding guidanceProviders should reference the most up-to-date professional coding guidance when submitting claims for these services.

    Imaging and Visualization Requirements

    Note

    Use fluoroscopy or endoscopic visualization as applicable

    Epidural adhesiolysis procedures require radiologic localization—fluoroscopy for percutaneous techniques or endoscopic visualization for epiduroscopy—depending on the technique used.

    • CPT descriptions for 62263/62264 include radiologic localization.
    • Endoscopic guidance provides 3‑D visualization during epiduroscopy.

    Not Covered Procedures

    Percutaneous and endoscopic epidural adhesiolysis procedures — including administration of hypertonic saline, use of hyaluronidase, mechanical catheter manipulation, and procedures performed under endoscopic visualization — are explicitly not covered because current medical literature does not support their efficacy.

    Policy Summary
    PayerCentene
    PolicyLysis of Epidural Lesions
    Policy CodePolicy CP MP.116
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionObtain prior authorization when requesting services billed with CPT 62263 or 62264 per plan rules.
    SourceLink
    On This Page
    Coverage Determination and CriteriaCoding ReferencesProvider Responsibilities and Billing GuidanceClinical BackgroundDefinitions of TechniquesRole of Prior Conservative Therapy in Evidence and PolicyProcedure Frequency and Session DescriptionsImaging and Visualization RequirementsNot Covered Procedures
  1. Policy outcome: despite that context, the literature is judged not supportive of efficacy.
  2. Documentation Required

    Use current CPT guidance and listed CPT descriptions when billing

    Reference current CPT guidance and the CPT code descriptions when submitting claims for percutaneous epidural adhesiolysis (62263, 62264).

    • 62263 — percutaneous lysis of epidural adhesions, multiple sessions; 2 or more days (CPT description).
    • 62264 — percutaneous lysis of epidural adhesions, multiple adhesiolysis sessions; 1 day (CPT description).
    • Inclusion of codes in the policy is informational and does not guarantee coverage.
    Denial Risk

    Coverage denial risk due to lack of supportive literature

    Be aware claims for percutaneous or endoscopic lysis of epidural adhesions may be denied because the policy states current medical literature does not support the efficacy of these procedures.

    • Policy explicitly states procedures for lysis of epidural lesions are not supported by current literature and are excluded from coverage.
    • Denial risk applies to percutaneous adhesiolysis, endoscopic adhesiolysis, and procedures with or without an indwelling Racz catheter.
    Endoscopic epidural adhesiolysis (epiduroscopy) — definition and notes
    DefinitionUse of spinal endoscopy (epiduroscopy) to visualize and mechanically divide epidural adhesions and to more precisely deliver injectate to the affected epidural space and nerve roots
    Visualization benefitEndoscopic guidance provides 3‑D visualization allowing targeted mechanical lysis and precise placement of therapeutic injectate onto nerve roots or scarred areas
    Evidence summaryResearch on endoscopic adhesiolysis is generally positive with improvements reported in observational studies and at least one RCT, but literature is limited in quantity and quality
    Technique noteA flexible fiberoptic catheter is inserted via the sacral hiatus to steer toward adhesions; prior to endoscopy adhesions may be identified as non‑filling defects on fluoroscopy